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To investigate the antigen recognized by cerebrospinal ﬂuid (CSF) high aﬃnity IgG in patients with multiple sclerosis (MS), the
phagedisplaymethodwasappliedtotheCSFfrom15MSand10controlpatients.PeptidesequencesrecognizedbyMSandcontrol
CSF IgG were individual speciﬁc, and no common motif was found. Peptide sequences frequently showed homology to various
kinds of amino acid sequences of ubiquitous viruses such as epstein barr virus (EBV) and herpes simplex virus (HSV), although
the frequency was not speciﬁc to MS patients. MS CSF IgG may recognize various types of ubiquitous viral antigen and may be
increased by a bystander response.
1.Introduction
In multiple sclerosis (MS), the pathogenetic events that
result in immune cell inﬁltration, multifocal demyelination,
and axonal loss are still under debate. Recognition has
emergedthatbothmutuallyinteractingcellularandhumoral
immune components may contribute to immune-mediated
demyelination in human disorders [1].
Normal cerebrospinal ﬂuid (CSF) has an IgG content
that is less than 13% of the total protein. In MS, there is an
unexplained elevation of IgG in the CSF from 15% to 30%,
visualized as oligoclonal bands (OB) after electrophoresis
[2].
Although the humoral immune response is implicated in
MS, its role in the pathogenesis has not been determined
precisely. Most researchers seem to consider MS CSF IgG
or oligoclonal IgG band to be a nonspeciﬁc bystander
response. On the other hand, several laboratories studied
the antigen-binding regions of antibodies found in MS brain
demyelinative plaques and cerebrospinal ﬂuid and revealed
(a) limited germline expression, results not expected for a
random bystander response; (b) features consistent with a
speciﬁc antigen-targeted process; (c) the clonal expansion of
populations of B lymphocytes in MS [2]. Furthermore, the
target antigen of MS CSF IgG has not been determined.
We have successfully conﬁrmed that CSF IgG from
HTLV-I-associated myelopathy/tropical spastic paraparesis
(HAM/TSP)patientsselectedmotifsthatwerehighlyhomol-
ogous to the causative microorganism “HTLV-I” from a 12-
mer random peptide library (RPL) using the phage display
method [3]. We tried to ﬁnd the target antigen of CSF IgG in
MS patients using the same method as we did in the cases of
HAM/TSP.
2.MaterialsandMethods
2.1. Patients and Controls. CSF samples from 15 MS patients
(13 women and 2 men, mean age 37 (range, 21–60) years,)
were analyzed. The mean onset age of the patients was 29
years, and the mean duration of the disease was 8 years.
The mean IgG index was 1.07. All MS patients fulﬁlled
McDonald’s criteria and the samples were obtained during
acute relapses of the disease. By testing with isoelectric
focusing and IgG immunoﬁxation method, 14 patients were2 Multiple Sclerosis International
found to be OB positive and one patient (MS7) was OB
negative. In a single patient (MS6), CSF samples collected at
three diﬀerent points of time were studied.
The control group was comprised of 5 patients with
psychosomatoform disorder and 5 patients with headache.
CSF samples from 10 control patients (5 men and 5 women),
mean age 28.7 years (range, 14–48), were analyzed.
2.2. Phage Display Method. One hundred microliters of
Dynabeads Protein A (Dynal Biotech ASA, Oslo, Norway)
were incubated with 300µL of CSF overnight at 4◦C. The
IgG-bead complexes were incubated with 10µL of a 12-
mer random peptide library containing approximately 4 ×
1010 particles (Ph.D-12, Phage Display Peptide Library Kit,
New England Biolabs, Beverly, MA) for 60 minutes at room
temperature. After washing twice with phosphate-buﬀered
saline containing 0.1% Tween-20, bound phages were eluted
and ampliﬁed by infecting Escherichia coli (ER2738 strain)
and incubated for 4.5h at 37◦C. Bacterial cells were removed
by centrifugation, and the ampliﬁed phages were puriﬁed by
polyethylene glycol (PEG) precipitation. The phage solution
was titrated to determine the concentration. Newly made
IgG-bead complexes were mixed for 60 minutes with the
2 × 1011 phage particles derived from the ﬁrst round phage
selection. After washing six times, bound phages were eluted.
Thirty-threeclonesfromthesecondroundofphageselection
were sequenced for DNA to determine the displayed 12-
mer amino acids. All these procedures were based on the
manufacturer’s protocol. The selected phage clones were
numbered in each patient. For example, p7 33 denoted the
33rd clone in patient MS7.
2.3. Homology Search for Selected Amino Acid Sequence
Motif. We searched for a common peptide motif, a speciﬁc
sequencepattern that occurs repeatedly in a group of peptide
sequences, using Multiple Expectation Maximum for Motif
Elicitation (MEME) version 3.0 (http://meme.sdsc.edu/
meme/cgi-bin/meme.cgi/)[ 4]. BLAST (Search for short
nearly exact matches, National Center for Biotechnology
Information) was searched for proteins containing homol-
ogous sequences.
3. Results
3.1. Phage Display. CSF from 13 out of 15 MS patients
and CSF from 8 out of 10 control patients selected one or
more common peptide motifs, but the peptide motifs were
basically diﬀerent from one patient to another (Tables 1 and
2). We tried to detect common peptide motifs in a total of
495 motifs derived from 15 MS patients, but we could not
detect any MS-speciﬁc common peptide motifs.
3.2. Homology Search. In the BLAST search, we could not
detect microbial agents or human molecules that signiﬁ-
cantly correlated with MS patients. However, we focused
on non-human sequences with the intention of obtaining
insight into etiological microbial agents of MS. The detected
peptide motifs were frequently homologous to the compo-
nents of herpes simplex virus 1 (HSV-1), cytomegalovirus
(CMV),andEBV,whilethesemotifswererarelyhomologous
to the components of measles virus, rubella virus, and
varicella zoster virus. As for putative myelin autoantigens in
MS, the motif of myelin basic protein was detected in only
one patient (MS5). In patient MS6, identical peptide motifs
homologous to the components of EBV were repeatedly
detected from the 3 CSF samples (Table 3). The Expect value
(E) is a parameter that describes the number of hits one can
“expect” to see by chance when searching a database of a
particular size. The lower the E-value, or the closer it is to
zero, the more “signiﬁcant” the match is. The E-values of
the three peptide motifs SPxxMH, DPYQxP, and PYxxYQxP
for EBV were 0.32, 0.008, 0.028, respectively, when we used
BLAST limiting the organism to viruses.
4. Discussion
Using molecular immunologic strategies, there have been
several analyses of intrathecally synthesized oligoclonally
expanded immunogloblins with high aﬃnity to identify spe-
ciﬁc antigens. The screening of libraries expressing protein
products derived from chronic MS plaque messenger RNA
with antibodies puriﬁed from plaques, CSF, or serum of
patients with MS has not thus far revealed the antigenic
targets of the MS antibody response [2].
The phage display method utilizes random peptide
libraries displayed on phages expressing a large collection
of peptide sequences (108 or more) that mimic linear or
conformational epitopes of folded protein domains, and
even carbohydrate structures [5–7]. We analyzed the binding
motifs of IgG in the CSF of HAM/TSP patients using the
phage library method [3]. As a result, sequences highly
homologous to HTLV-I gp46 were the common linear
epitopesofhighaﬃnity-IgGexclusivelydetectedinbothCSF
and sera of the patients.
A few laboratories have previously reported the selection
from RPL of several peptides that bind to antibodies present
in the CSF of Caucasian MS patients. However, the results
are still inconsistent. Rand and colleagues reported that CSF
IgG antibody selected the amino acid sequence motif RRPFF
from a random peptide library in ﬁve out of 14 American
patients with MS. The RRPFF motif is found in EBV nuclear
antigen [8]. Cortese and colleagues carried out a similar
study of CSF from Italian patients with MS using the phage
display method. Three diﬀerent candidate amino acid motifs
selected by CSF from two patients with MS were tested and,
whereas they were recognized with equal frequency by serum
from both MS and control patients, CSF from only 4 out of
55 patients with MS reacted with one of these three motifs.
With another experiment, they concluded that CSF-enriched
antibodies did not share speciﬁcities among MS patients
[9, 10]. We tried to ﬁnd a common motif with a 12-mer
peptide library in a larger cohort than those in the previous
studies.
After conﬁrming that the phage display method com-
bined with MEME and BLAST search could detect the target
antigen of CSF IgG from HAM/TSP patients, we investigated
the potential target antigens recognized by high aﬃnity
IgG in MS CSF using the phage display method. However,Multiple Sclerosis International 3
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Table 2: Common peptide motifs in control group.
Cont 1 Cont 2 Cont 3 Cont 4 Cont 5 Cont 6 Cont 7 Cont 8 Cont 9 Cont 10
[IHHPAHG] [NPIEAF] [KPPNP] [GVTDY] [HILHNPF] [GPALSxSE] [KPPNPS] [IYPTTLPW]
IHHPAHG NPVENF KPPNP GVQDY HILHNPF RPALSMYE KPPNPM IYRTTLPW
MHHPAHQ NHCCAF KPPNP GVHDY HSLHNPF RPALSMYE KPPNPM IYPTTLPW
SHHPAHG NPIELW KPPNP GMTDY HLLHSPF MPALSVSE KPPNPS IYTVTLPW
NHHPAHM NPIVNY KPPNP GLIDY HYAHNPF GPALSHSE KPPNPS
NPVLAW KPPNP QITDY HNHHNPF RPALTPQE KPPNPS [YLDL]
[YLPK] NPIEKL KPPNP HIMHDPL QPALSSTE KPPNPE
NPVLTF [LPHWSP] HNLHSPW MPMLSAEE KPPNPT YYDL
YLPK [SLQSLRAAAM] SPHISNKE KPPNPL YLDL
YEPQ LPHWSP GPSLLNVE YPDL
YLSK SIQSLRTAFM LPHWSP TPALHRLE
YLPT SLQSLRGASA LPHWMP VPTLNVAE
SLSSLRAAAF LPHWQP GPSLHPSE
SVRSLHERVM LPHWSF MPGLPSQE
IRHWVP SPATYFLE
SPQLSAHG
[PWSK]
PWSK
PWSK
PWSK
PWSK
PWSK
PWSK
PWSK
PWSK
Parentheses indicate common peptide motifs in a control case.
Peptide sequences derived from random peptide library are listed below.
Table 3: Common peptide motifs derived from 3 CSF samples of
MS6.
Peptide motifs
(SPxxMH) (DPYQxP) (PYxxYQxP)
1999.12
(Remission)
SPPKMH DPYQVPP Y EFYQYP
SPKSMH GPYQDPP Y LNYQHP
SPPLMH DPYQLP
SPRNMH
SPVHMH
2000.1
(Relapse)
SPRIDHD P Y Q LPP Y TGYQ
SPPLMH DPYQSL PYAGYQ
DPYQVY
DQYQQP
2000.10
(Remission)
SPYHSHD YYQQH PYSPYQLP
SPRNMH DPYQTA PYNLYQTP
SPGNMH DPYQLP TYGAYQLA
PYAHYQPY
EBV component IYYSPSIMHRP DPYQLPFA APYQGYQEPP
(EBV VP19) (EBV ZEBRA) (EBV EBNA 6)
Bold-faced letter indicates common peptide motifs.
we could not detect a peptide sequence or antigen that is
recognized exclusively by CSF IgG from most of MS patients.
One possible reason that we could not detect an epitope
is that the MS CSF IgG may recognize a conformational
epitope or nonprotein antigens. Another possible reason is
that MS CSF IgG may recognize epitopes with lower aﬃnity
that may not exist dominantly compared to HAM CSF IgG.
In our study, CSF IgG from two MS patients with OCB could
not recognize common peptide motifs. When exploring MS
CSF IgG epitopes using the phage display method, it might
be necessary to sequence much larger numbers of phage
clones and to increase the number of pannings. It is still
diﬃcult to conclude that the MS CSF IgG antigen does not
exist. However, considering the fact that no MS antigen has
been determined so far, MS CSF IgG may not recognize
a single MS antigen, diﬀering from HAM/TSP CSF IgG
which recognizes HTLV-I. Also, the fact that the common
peptide motifs detected in MS and control groups were not
signiﬁcantly diﬀe r e n tm a ys u g g e s tt h a tM SC S FI g Gm a y
recognize ubiquitous antigens, also diﬀering from the case
of HAM/TSP CSF IgG.
Interestingly, in patient MS6, identical peptide motifs
homologous to the components of EBV were repeatedly
detected from the 3 CSF samples. The E-values of the three
peptide motifs from MS-6 for EBV were 0.008–0.32. In the
former study, the E-values of the common peptide motifs
from HAM/TSP CSF IgG for HTLV-I were 0.15–0.95. The
peptide motifs were indicative of the EBV speciﬁcity. MSMultiple Sclerosis International 5
CSF IgG may recognize antigens persistently and epitope
spreading may not occur in some patients.
Recently, Meinl and colleagues reported that inﬂamma-
tion in the central nervous system (CNS) provides a unique,
B-cell-friendlyenvironment,inwhichBlineagecells,notably
long-lived plasma cells, can survive for many years. These
long-lived plasma cells may produce oligoclonal IgG bands.
CNSresidentcells(mainlyastrocytesandmicroglia)produce
mediators such as chemokines, cytokines, and adhesion
molecules that promote the local survival of plasma cells
[11]. Whether the antibodies derived from these long-
lived plasma cells target speciﬁc antigens or nonspeciﬁc
ubiquitous antigens remains to be determined.
MS CSF IgG is considered to be oligoclonally increased,
and the factor that evokes this response may not be a sin-
gle, rare MS antigen. Other factors that survive speciﬁc
B cells may evoke this response. Such factors, rather than
a single rare antigen, may be common in the pathogenesis
of MS. Further analysis of such factors may be critical to
understanding the pathogenesis of MS.
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